The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Covid-19 Vaccine Market Insights and Forecast to 2028
Synopsis
A COVID-19 vaccine is a hypothetical vaccine against coronavirus disease 2019 (COVID-19). Although no vaccine has completed clinical trials, there are multiple attempts in progress to develop such a vaccine.
The genetic sequence of SARS-CoV-2, the coronavirus that causes COVID-19, was published on 11 January 2020, triggering intense global R&D activity to develop a vaccine against the disease. The scale of the humanitarian and economic impact of the COVID-19 pandemic is driving evaluation of next-generation vaccine technology platforms through novel paradigms to accelerate development, and the first COVID-19 vaccine candidate entered human clinical testing with unprecedented rapidity on 16 March 2020.
The global vaccine R&D effort in response to the COVID-19 pandemic is unprecedented in terms of scale and speed. Given the imperative for speed, there is an indication that vaccine could be available under emergency use or similar protocols by early 2021. This would represent a fundamental step change from the traditional vaccine development pathway, which takes on average over 10 years, even compared with the accelerated 5-year timescale for development of the first Ebola vaccine, and will necessitate novel vaccine development paradigms involving parallel and adaptive development phases, innovative regulatory processes and scaling manufacturing capacity.
Market Analysis and Insights: Global Covid-19 Vaccine Market
The global Covid-19 Vaccine market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
North America is the largest consumption place, with a consumption market share nearly 53.8% in 2026, Europe is the second largest consumption place with the consumption market share of 24.61% in 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Covid-19 Vaccine market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Covid-19 Vaccine market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Covid-19 Vaccine market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Covid-19 Vaccine market.
Global Covid-19 Vaccine Scope and Market Size
Covid-19 Vaccine market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Covid-19 Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
DNA
Non-replicating Viral Vector
Protein Subunit
RNA
Others
Segment by Application
Adults
Children
By Company
Moderna
CanSino Biologicals
Inovio Pharmaceuticals
Shenzhen Geno-Immune Medical Institute
GlaxoSmithKine
Pfizer
Johnson＆Johnson
Heat Biologics
Sanofi
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
A COVID-19 vaccine is a hypothetical vaccine against coronavirus disease 2019 (COVID-19). Although no vaccine has completed clinical trials, there are multiple attempts in progress to develop such a vaccine.
The genetic sequence of SARS-CoV-2, the coronavirus that causes COVID-19, was published on 11 January 2020, triggering intense global R&D activity to develop a vaccine against the disease. The scale of the humanitarian and economic impact of the COVID-19 pandemic is driving evaluation of next-generation vaccine technology platforms through novel paradigms to accelerate development, and the first COVID-19 vaccine candidate entered human clinical testing with unprecedented rapidity on 16 March 2020.
The global vaccine R&D effort in response to the COVID-19 pandemic is unprecedented in terms of scale and speed. Given the imperative for speed, there is an indication that vaccine could be available under emergency use or similar protocols by early 2021. This would represent a fundamental step change from the traditional vaccine development pathway, which takes on average over 10 years, even compared with the accelerated 5-year timescale for development of the first Ebola vaccine, and will necessitate novel vaccine development paradigms involving parallel and adaptive development phases, innovative regulatory processes and scaling manufacturing capacity.
Market Analysis and Insights: Global Covid-19 Vaccine Market
The global Covid-19 Vaccine market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
North America is the largest consumption place, with a consumption market share nearly 53.8% in 2026, Europe is the second largest consumption place with the consumption market share of 24.61% in 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Covid-19 Vaccine market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Covid-19 Vaccine market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Covid-19 Vaccine market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Covid-19 Vaccine market.
Global Covid-19 Vaccine Scope and Market Size
Covid-19 Vaccine market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Covid-19 Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
DNA
Non-replicating Viral Vector
Protein Subunit
RNA
Others
Segment by Application
Adults
Children
By Company
Moderna
CanSino Biologicals
Inovio Pharmaceuticals
Shenzhen Geno-Immune Medical Institute
GlaxoSmithKine
Pfizer
Johnson＆Johnson
Heat Biologics
Sanofi
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Index1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Covid-19 Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 DNA
1.2.3 Non-replicating Viral Vector
1.2.4 Protein Subunit
1.2.5 RNA
1.2.6 Others
1.3 Market by Application
1.3.1 Global Covid-19 Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Adults
1.3.3 Children
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Covid-19 Vaccine Market Perspective (2017-2028)
2.2 Covid-19 Vaccine Growth Trends by Region
2.2.1 Covid-19 Vaccine Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Covid-19 Vaccine Historic Market Size by Region (2017-2022)
2.2.3 Covid-19 Vaccine Forecasted Market Size by Region (2023-2028)
2.3 Covid-19 Vaccine Market Dynamics
2.3.1 Covid-19 Vaccine Industry Trends
2.3.2 Covid-19 Vaccine Market Drivers
2.3.3 Covid-19 Vaccine Market Challenges
2.3.4 Covid-19 Vaccine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Covid-19 Vaccine Players by Revenue
3.1.1 Global Top Covid-19 Vaccine Players by Revenue (2017-2022)
3.1.2 Global Covid-19 Vaccine Revenue Market Share by Players (2017-2022)
3.2 Global Covid-19 Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Covid-19 Vaccine Revenue
3.4 Global Covid-19 Vaccine Market Concentration Ratio
3.4.1 Global Covid-19 Vaccine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Covid-19 Vaccine Revenue in 2021
3.5 Covid-19 Vaccine Key Players Head office and Area Served
3.6 Key Players Covid-19 Vaccine Product Solution and Service
3.7 Date of Enter into Covid-19 Vaccine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Covid-19 Vaccine Breakdown Data by Type
4.1 Global Covid-19 Vaccine Historic Market Size by Type (2017-2022)
4.2 Global Covid-19 Vaccine Forecasted Market Size by Type (2023-2028)
5 Covid-19 Vaccine Breakdown Data by Application
5.1 Global Covid-19 Vaccine Historic Market Size by Application (2017-2022)
5.2 Global Covid-19 Vaccine Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Covid-19 Vaccine Market Size (2017-2028)
6.2 North America Covid-19 Vaccine Market Size by Type
6.2.1 North America Covid-19 Vaccine Market Size by Type (2017-2022)
6.2.2 North America Covid-19 Vaccine Market Size by Type (2023-2028)
6.2.3 North America Covid-19 Vaccine Market Share by Type (2017-2028)
6.3 North America Covid-19 Vaccine Market Size by Application
6.3.1 North America Covid-19 Vaccine Market Size by Application (2017-2022)
6.3.2 North America Covid-19 Vaccine Market Size by Application (2023-2028)
6.3.3 North America Covid-19 Vaccine Market Share by Application (2017-2028)
6.4 North America Covid-19 Vaccine Market Size by Country
6.4.1 North America Covid-19 Vaccine Market Size by Country (2017-2022)
6.4.2 North America Covid-19 Vaccine Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Covid-19 Vaccine Market Size (2017-2028)
7.2 Europe Covid-19 Vaccine Market Size by Type
7.2.1 Europe Covid-19 Vaccine Market Size by Type (2017-2022)
7.2.2 Europe Covid-19 Vaccine Market Size by Type (2023-2028)
7.2.3 Europe Covid-19 Vaccine Market Share by Type (2017-2028)
7.3 Europe Covid-19 Vaccine Market Size by Application
7.3.1 Europe Covid-19 Vaccine Market Size by Application (2017-2022)
7.3.2 Europe Covid-19 Vaccine Market Size by Application (2023-2028)
7.3.3 Europe Covid-19 Vaccine Market Share by Application (2017-2028)
7.4 Europe Covid-19 Vaccine Market Size by Country
7.4.1 Europe Covid-19 Vaccine Market Size by Country (2017-2022)
7.4.2 Europe Covid-19 Vaccine Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Covid-19 Vaccine Market Size (2017-2028)
8.2 Asia-Pacific Covid-19 Vaccine Market Size by Type
8.2.1 Asia-Pacific Covid-19 Vaccine Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Covid-19 Vaccine Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Covid-19 Vaccine Market Share by Type (2017-2028)
8.3 Asia-Pacific Covid-19 Vaccine Market Size by Application
8.3.1 Asia-Pacific Covid-19 Vaccine Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Covid-19 Vaccine Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Covid-19 Vaccine Market Share by Application (2017-2028)
8.4 Asia-Pacific Covid-19 Vaccine Market Size by Region
8.4.1 Asia-Pacific Covid-19 Vaccine Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Covid-19 Vaccine Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Covid-19 Vaccine Market Size (2017-2028)
9.2 Latin America Covid-19 Vaccine Market Size by Type
9.2.1 Latin America Covid-19 Vaccine Market Size by Type (2017-2022)
9.2.2 Latin America Covid-19 Vaccine Market Size by Type (2023-2028)
9.2.3 Latin America Covid-19 Vaccine Market Share by Type (2017-2028)
9.3 Latin America Covid-19 Vaccine Market Size by Application
9.3.1 Latin America Covid-19 Vaccine Market Size by Application (2017-2022)
9.3.2 Latin America Covid-19 Vaccine Market Size by Application (2023-2028)
9.3.3 Latin America Covid-19 Vaccine Market Share by Application (2017-2028)
9.4 Latin America Covid-19 Vaccine Market Size by Country
9.4.1 Latin America Covid-19 Vaccine Market Size by Country (2017-2022)
9.4.2 Latin America Covid-19 Vaccine Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Covid-19 Vaccine Market Size (2017-2028)
10.2 Middle East & Africa Covid-19 Vaccine Market Size by Type
10.2.1 Middle East & Africa Covid-19 Vaccine Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Covid-19 Vaccine Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Covid-19 Vaccine Market Share by Type (2017-2028)
10.3 Middle East & Africa Covid-19 Vaccine Market Size by Application
10.3.1 Middle East & Africa Covid-19 Vaccine Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Covid-19 Vaccine Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Covid-19 Vaccine Market Share by Application (2017-2028)
10.4 Middle East & Africa Covid-19 Vaccine Market Size by Country
10.4.1 Middle East & Africa Covid-19 Vaccine Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Covid-19 Vaccine Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Moderna
11.1.1 Moderna Company Details
11.1.2 Moderna Business Overview
11.1.3 Moderna Covid-19 Vaccine Introduction
11.1.4 Moderna Revenue in Covid-19 Vaccine Business (2017-2022)
11.1.5 Moderna Recent Developments
11.2 CanSino Biologicals
11.2.1 CanSino Biologicals Company Details
11.2.2 CanSino Biologicals Business Overview
11.2.3 CanSino Biologicals Covid-19 Vaccine Introduction
11.2.4 CanSino Biologicals Revenue in Covid-19 Vaccine Business (2017-2022)
11.2.5 CanSino Biologicals Recent Developments
11.3 Inovio Pharmaceuticals
11.3.1 Inovio Pharmaceuticals Company Details
11.3.2 Inovio Pharmaceuticals Business Overview
11.3.3 Inovio Pharmaceuticals Covid-19 Vaccine Introduction
11.3.4 Inovio Pharmaceuticals Revenue in Covid-19 Vaccine Business (2017-2022)
11.3.5 Inovio Pharmaceuticals Recent Developments
11.4 Shenzhen Geno-Immune Medical Institute
11.4.1 Shenzhen Geno-Immune Medical Institute Company Details
11.4.2 Shenzhen Geno-Immune Medical Institute Business Overview
11.4.3 Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Introduction
11.4.4 Shenzhen Geno-Immune Medical Institute Revenue in Covid-19 Vaccine Business (2017-2022)
11.4.5 Shenzhen Geno-Immune Medical Institute Recent Developments
11.5 GlaxoSmithKine
11.5.1 GlaxoSmithKine Company Details
11.5.2 GlaxoSmithKine Business Overview
11.5.3 GlaxoSmithKine Covid-19 Vaccine Introduction
11.5.4 GlaxoSmithKine Revenue in Covid-19 Vaccine Business (2017-2022)
11.5.5 GlaxoSmithKine Recent Developments
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Covid-19 Vaccine Introduction
11.6.4 Pfizer Revenue in Covid-19 Vaccine Business (2017-2022)
11.6.5 Pfizer Recent Developments
11.7 Johnson＆Johnson
11.7.1 Johnson＆Johnson Company Details
11.7.2 Johnson＆Johnson Business Overview
11.7.3 Johnson＆Johnson Covid-19 Vaccine Introduction
11.7.4 Johnson＆Johnson Revenue in Covid-19 Vaccine Business (2017-2022)
11.7.5 Johnson＆Johnson Recent Developments
11.8 Heat Biologics
11.8.1 Heat Biologics Company Details
11.8.2 Heat Biologics Business Overview
11.8.3 Heat Biologics Covid-19 Vaccine Introduction
11.8.4 Heat Biologics Revenue in Covid-19 Vaccine Business (2017-2022)
11.8.5 Heat Biologics Recent Developments
11.9 Sanofi
11.9.1 Sanofi Company Details
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Covid-19 Vaccine Introduction
11.9.4 Sanofi Revenue in Covid-19 Vaccine Business (2017-2022)
11.9.5 Sanofi Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of TablesList of Tables
Table 1. Global Covid-19 Vaccine Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of DNA
Table 3. Key Players of Non-replicating Viral Vector
Table 4. Key Players of Protein Subunit
Table 5. Key Players of RNA
Table 6. Key Players of Others
Table 7. Global Covid-19 Vaccine Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 8. Global Covid-19 Vaccine Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Covid-19 Vaccine Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Covid-19 Vaccine Market Share by Region (2017-2022)
Table 11. Global Covid-19 Vaccine Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Covid-19 Vaccine Market Share by Region (2023-2028)
Table 13. Covid-19 Vaccine Market Trends
Table 14. Covid-19 Vaccine Market Drivers
Table 15. Covid-19 Vaccine Market Challenges
Table 16. Covid-19 Vaccine Market Restraints
Table 17. Global Covid-19 Vaccine Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Covid-19 Vaccine Revenue Share by Players (2017-2022)
Table 19. Global Top Covid-19 Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Covid-19 Vaccine as of 2021)
Table 20. Ranking of Global Top Covid-19 Vaccine Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Covid-19 Vaccine Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Covid-19 Vaccine Product Solution and Service
Table 24. Date of Enter into Covid-19 Vaccine Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Covid-19 Vaccine Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Covid-19 Vaccine Revenue Market Share by Type (2017-2022)
Table 28. Global Covid-19 Vaccine Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Covid-19 Vaccine Revenue Market Share by Type (2023-2028)
Table 30. Global Covid-19 Vaccine Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Covid-19 Vaccine Revenue Share by Application (2017-2022)
Table 32. Global Covid-19 Vaccine Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Covid-19 Vaccine Revenue Share by Application (2023-2028)
Table 34. North America Covid-19 Vaccine Market Size by Type (2017-2022) & (US$ Million)
Table 35. North America Covid-19 Vaccine Market Size by Type (2023-2028) & (US$ Million)
Table 36. North America Covid-19 Vaccine Market Size by Application (2017-2022) & (US$ Million)
Table 37. North America Covid-19 Vaccine Market Size by Application (2023-2028) & (US$ Million)
Table 38. North America Covid-19 Vaccine Market Size by Country (2017-2022) & (US$ Million)
Table 39. North America Covid-19 Vaccine Market Size by Country (2023-2028) & (US$ Million)
Table 40. Europe Covid-19 Vaccine Market Size by Type (2017-2022) & (US$ Million)
Table 41. Europe Covid-19 Vaccine Market Size by Type (2023-2028) & (US$ Million)
Table 42. Europe Covid-19 Vaccine Market Size by Application (2017-2022) & (US$ Million)
Table 43. Europe Covid-19 Vaccine Market Size by Application (2023-2028) & (US$ Million)
Table 44. Europe Covid-19 Vaccine Market Size by Country (2017-2022) & (US$ Million)
Table 45. Europe Covid-19 Vaccine Market Size by Country (2023-2028) & (US$ Million)
Table 46. Asia Pacific Covid-19 Vaccine Market Size by Type (2017-2022) & (US$ Million)
Table 47. Asia Pacific Covid-19 Vaccine Market Size by Type (2023-2028) & (US$ Million)
Table 48. Asia Pacific Covid-19 Vaccine Market Size by Application (2017-2022) & (US$ Million)
Table 49. Asia Pacific Covid-19 Vaccine Market Size by Application (2023-2028) & (US$ Million)
Table 50. Asia Pacific Covid-19 Vaccine Market Size by Region (2017-2022) & (US$ Million)
Table 51. Asia Pacific Covid-19 Vaccine Market Size by Region (2023-2028) & (US$ Million)
Table 52. Latin America Covid-19 Vaccine Market Size by Type (2017-2022) & (US$ Million)
Table 53. Latin America Covid-19 Vaccine Market Size by Type (2023-2028) & (US$ Million)
Table 54. Latin America Covid-19 Vaccine Market Size by Application (2017-2022) & (US$ Million)
Table 55. Latin America Covid-19 Vaccine Market Size by Application (2023-2028) & (US$ Million)
Table 56. Latin America Covid-19 Vaccine Market Size by Country (2017-2022) & (US$ Million)
Table 57. Latin America Covid-19 Vaccine Market Size by Country (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Covid-19 Vaccine Market Size by Type (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Covid-19 Vaccine Market Size by Type (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Covid-19 Vaccine Market Size by Application (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Covid-19 Vaccine Market Size by Application (2023-2028) & (US$ Million)
Table 62. Middle East and Africa Covid-19 Vaccine Market Size by Country (2017-2022) & (US$ Million)
Table 63. Middle East and Africa Covid-19 Vaccine Market Size by Country (2023-2028) & (US$ Million)
Table 64. Moderna Company Details
Table 65. Moderna Business Overview
Table 66. Moderna Covid-19 Vaccine Product
Table 67. Moderna Revenue in Covid-19 Vaccine Business (2017-2022) & (US$ Million)
Table 68. Moderna Recent Developments
Table 69. CanSino Biologicals Company Details
Table 70. CanSino Biologicals Business Overview
Table 71. CanSino Biologicals Covid-19 Vaccine Product
Table 72. CanSino Biologicals Revenue in Covid-19 Vaccine Business (2017-2022) & (US$ Million)
Table 73. CanSino Biologicals Recent Developments
Table 74. Inovio Pharmaceuticals Company Details
Table 75. Inovio Pharmaceuticals Business Overview
Table 76. Inovio Pharmaceuticals Covid-19 Vaccine Product
Table 77. Inovio Pharmaceuticals Revenue in Covid-19 Vaccine Business (2017-2022) & (US$ Million)
Table 78. Inovio Pharmaceuticals Recent Developments
Table 79. Shenzhen Geno-Immune Medical Institute Company Details
Table 80. Shenzhen Geno-Immune Medical Institute Business Overview
Table 81. Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Product
Table 82. Shenzhen Geno-Immune Medical Institute Revenue in Covid-19 Vaccine Business (2017-2022) & (US$ Million)
Table 83. Shenzhen Geno-Immune Medical Institute Recent Developments
Table 84. GlaxoSmithKine Company Details
Table 85. GlaxoSmithKine Business Overview
Table 86. GlaxoSmithKine Covid-19 Vaccine Product
Table 87. GlaxoSmithKine Revenue in Covid-19 Vaccine Business (2017-2022) & (US$ Million)
Table 88. GlaxoSmithKine Recent Developments
Table 89. Pfizer Company Details
Table 90. Pfizer Business Overview
Table 91. Pfizer Covid-19 Vaccine Product
Table 92. Pfizer Revenue in Covid-19 Vaccine Business (2017-2022) & (US$ Million)
Table 93. Pfizer Recent Developments
Table 94. Johnson＆Johnson Company Details
Table 95. Johnson＆Johnson Business Overview
Table 96. Johnson＆Johnson Covid-19 Vaccine Product
Table 97. Johnson＆Johnson Revenue in Covid-19 Vaccine Business (2017-2022) & (US$ Million)
Table 98. Johnson＆Johnson Recent Developments
Table 99. Heat Biologics Company Details
Table 100. Heat Biologics Business Overview
Table 101. Heat Biologics Covid-19 Vaccine Product
Table 102. Heat Biologics Revenue in Covid-19 Vaccine Business (2017-2022) & (US$ Million)
Table 103. Heat Biologics Recent Developments
Table 104. Sanofi Company Details
Table 105. Sanofi Business Overview
Table 106. Sanofi Covid-19 Vaccine Product
Table 107. Sanofi Revenue in Covid-19 Vaccine Business (2017-2022) & (US$ Million)
Table 108. Sanofi Recent Developments
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Covid-19 Vaccine Market Share by Type: 2021 VS 2028
Figure 2. DNA Features
Figure 3. Non-replicating Viral Vector Features
Figure 4. Protein Subunit Features
Figure 5. RNA Features
Figure 6. Others Features
Figure 7. Global Covid-19 Vaccine Market Share by Application: 2021 VS 2028
Figure 8. Adults Case Studies
Figure 9. Children Case Studies
Figure 10. Covid-19 Vaccine Report Years Considered
Figure 11. Global Covid-19 Vaccine Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Covid-19 Vaccine Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Covid-19 Vaccine Market Share by Region: 2021 VS 2028
Figure 14. Global Covid-19 Vaccine Market Share by Players in 2021
Figure 15. Global Top Covid-19 Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Covid-19 Vaccine as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Covid-19 Vaccine Revenue in 2021
Figure 17. North America Covid-19 Vaccine Market Size YoY (2017-2028) & (US$ Million)
Figure 18. North America Covid-19 Vaccine Market Size Market Share by Type (2017-2028)
Figure 19. North America Covid-19 Vaccine Market Size Market Share by Application (2017-2028)
Figure 20. North America Covid-19 Vaccine Market Size Share by Country (2017-2028)
Figure 21. United States Covid-19 Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Covid-19 Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Covid-19 Vaccine Market Size YoY (2017-2028) & (US$ Million)
Figure 24. Europe Covid-19 Vaccine Market Size Market Share by Type (2017-2028)
Figure 25. Europe Covid-19 Vaccine Market Size Market Share by Application (2017-2028)
Figure 26. Europe Covid-19 Vaccine Market Size Share by Country (2017-2028)
Figure 27. Germany Covid-19 Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France Covid-19 Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. Covid-19 Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy Covid-19 Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia Covid-19 Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries Covid-19 Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Covid-19 Vaccine Market Size YoY (2017-2028) & (US$ Million)
Figure 34. Asia Pacific Covid-19 Vaccine Market Size Market Share by Type (2017-2028)
Figure 35. Asia Pacific Covid-19 Vaccine Market Size Market Share by Application (2017-2028)
Figure 36. Asia Pacific Covid-19 Vaccine Market Size Share by Region (2017-2028)
Figure 37. China Covid-19 Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Japan Covid-19 Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. South Korea Covid-19 Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Southeast Asia Covid-19 Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. India Covid-19 Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Australia Covid-19 Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Latin America Covid-19 Vaccine Market Size YoY (2017-2028) & (US$ Million)
Figure 44. Latin America Covid-19 Vaccine Market Size Market Share by Type (2017-2028)
Figure 45. Latin America Covid-19 Vaccine Market Size Market Share by Application (2017-2028)
Figure 46. Latin America Covid-19 Vaccine Market Size Share by Country (2017-2028)
Figure 47. Mexico Covid-19 Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Brazil Covid-19 Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Covid-19 Vaccine Market Size YoY (2017-2028) & (US$ Million)
Figure 50. Middle East and Africa Covid-19 Vaccine Market Size Market Share by Type (2017-2028)
Figure 51. Middle East and Africa Covid-19 Vaccine Market Size Market Share by Application (2017-2028)
Figure 52. Middle East and Africa Covid-19 Vaccine Market Size Share by Country (2017-2028)
Figure 53. Turkey Covid-19 Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Covid-19 Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. UAE Covid-19 Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Moderna Revenue Growth Rate in Covid-19 Vaccine Business (2017-2022)
Figure 57. CanSino Biologicals Revenue Growth Rate in Covid-19 Vaccine Business (2017-2022)
Figure 58. Inovio Pharmaceuticals Revenue Growth Rate in Covid-19 Vaccine Business (2017-2022)
Figure 59. Shenzhen Geno-Immune Medical Institute Revenue Growth Rate in Covid-19 Vaccine Business (2017-2022)
Figure 60. GlaxoSmithKine Revenue Growth Rate in Covid-19 Vaccine Business (2017-2022)
Figure 61. Pfizer Revenue Growth Rate in Covid-19 Vaccine Business (2017-2022)
Figure 62. Johnson＆Johnson Revenue Growth Rate in Covid-19 Vaccine Business (2017-2022)
Figure 63. Heat Biologics Revenue Growth Rate in Covid-19 Vaccine Business (2017-2022)
Figure 64. Sanofi Revenue Growth Rate in Covid-19 Vaccine Business (2017-2022)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
